Eli Lilly And Stock Market Value
| LLY Stock | USD 972.88 0.00 0.00% |
| Symbol | Eli |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. Expected growth trajectory for Eli significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Eli Lilly assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.514 | Dividend Share 6 | Earnings Share 22.98 | Revenue Per Share | Quarterly Revenue Growth 0.426 |
The market value of Eli Lilly is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Eli Lilly's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Eli Lilly represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Eli Lilly's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Eli Lilly 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eli Lilly's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eli Lilly.
| 12/05/2025 |
| 03/05/2026 |
If you would invest 0.00 in Eli Lilly on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding Eli Lilly and or generate 0.0% return on investment in Eli Lilly over 90 days. Eli Lilly is related to or competes with Johnson Johnson, AstraZeneca PLC, AbbVie, Novartis, Amgen, Novo Nordisk, and Merck. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide More
Eli Lilly Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eli Lilly's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eli Lilly and upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 18.12 | |||
| Value At Risk | (3.60) | |||
| Potential Upside | 3.66 |
Eli Lilly Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eli Lilly's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eli Lilly's standard deviation. In reality, there are many statistical measures that can use Eli Lilly historical prices to predict the future Eli Lilly's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | 0.1574 |
Eli Lilly March 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.1674 | |||
| Mean Deviation | 1.69 | |||
| Coefficient Of Variation | (2,147) | |||
| Standard Deviation | 2.46 | |||
| Variance | 6.03 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | 0.1574 | |||
| Maximum Drawdown | 18.12 | |||
| Value At Risk | (3.60) | |||
| Potential Upside | 3.66 | |||
| Skewness | 0.9205 | |||
| Kurtosis | 5.13 |
Eli Lilly Backtested Returns
At this stage we consider Eli Stock to be very steady. Eli Lilly secures Sharpe Ratio (or Efficiency) of 0.0117, which denotes the company had a 0.0117 % return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Eli Lilly and, which you can use to evaluate the volatility of the firm. Please confirm Eli Lilly's Variance of 6.03, mean deviation of 1.69, and Standard Deviation of 2.46 to check if the risk estimate we provide is consistent with the expected return of 0.0296%. The firm shows a Beta (market volatility) of -0.79, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Eli Lilly are expected to decrease at a much lower rate. During the bear market, Eli Lilly is likely to outperform the market. Eli Lilly right now shows a risk of 2.53%. Please confirm Eli Lilly standard deviation, potential upside, as well as the relationship between the Potential Upside and day typical price , to decide if Eli Lilly will be following its price patterns.
Auto-correlation | -0.46 |
Modest reverse predictability
Eli Lilly and has modest reverse predictability. Overlapping area represents the amount of predictability between Eli Lilly time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eli Lilly price movement. The serial correlation of -0.46 indicates that about 46.0% of current Eli Lilly price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.46 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 547.47 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.